156 related articles for article (PubMed ID: 21413009)
21. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J
Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of endogenous hormones and breast cancer.
Helzlsouer KJ; Alberg AJ; Bush TL; Longcope C; Gordon GB; Comstock GW
Cancer Detect Prev; 1994; 18(2):79-85. PubMed ID: 8025899
[TBL] [Abstract][Full Text] [Related]
23. Maternal Pregnancy Hormone Concentrations in Countries with Very Low and High Breast Cancer Risk.
Ganmaa D; Enkhmaa D; Baatar T; Uyanga B; Gantsetseg G; Helde TT; McElrath TF; Cantonwine DE; Bradwin G; Falk RT; Hoover RN; Troisi R
Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 32012981
[TBL] [Abstract][Full Text] [Related]
24. Serum sex hormone levels are related to breast cancer risk in postmenopausal women.
Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):583-5. PubMed ID: 9167999
[TBL] [Abstract][Full Text] [Related]
25. Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT.
Dallal CM; Tice JA; Buist DS; Bauer DC; Lacey JV; Cauley JA; Hue TF; Lacroix A; Falk RT; Pfeiffer RM; Fuhrman BJ; Veenstra TD; Xu X; Brinton LA;
Carcinogenesis; 2014 Feb; 35(2):346-55. PubMed ID: 24213602
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).
Sturgeon SR; Potischman N; Malone KE; Dorgan JF; Daling J; Schairer C; Brinton LA
Cancer Causes Control; 2004 Feb; 15(1):45-53. PubMed ID: 14970734
[TBL] [Abstract][Full Text] [Related]
27. Third Trimester Estrogens and Maternal Breast Cancer: Prospective Evidence.
Cohn BA; Cirillo PM; Hopper BR; Siiteri PK
J Clin Endocrinol Metab; 2017 Oct; 102(10):3739-3748. PubMed ID: 28973345
[TBL] [Abstract][Full Text] [Related]
28. Circulating insulin-like growth factor-I in pregnancy and maternal risk of breast cancer.
Toriola AT; Lundin E; Schock H; Grankvist K; Pukkala E; Chen T; Zeleniuch-Jacquotte A; Toniolo P; Lehtinen M; Surcel HM; Lukanova A
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1798-801. PubMed ID: 21680537
[TBL] [Abstract][Full Text] [Related]
29. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.
Adly L; Hill D; Sherman ME; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Schairer C
Int J Cancer; 2006 Nov; 119(10):2402-7. PubMed ID: 16894564
[TBL] [Abstract][Full Text] [Related]
30. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.
Zeleniuch-Jacquotte A; Bruning PF; Bonfrer JM; Koenig KL; Shore RE; Kim MY; Pasternack BS; Toniolo P
Am J Epidemiol; 1997 Jun; 145(11):1030-8. PubMed ID: 9169912
[TBL] [Abstract][Full Text] [Related]
31. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.
Key T; Appleby P; Barnes I; Reeves G;
J Natl Cancer Inst; 2002 Apr; 94(8):606-16. PubMed ID: 11959894
[TBL] [Abstract][Full Text] [Related]
32. IGF-I during primiparous pregnancy and maternal risk of breast cancer.
Chen T; Lukanova A; Grankvist K; Zeleniuch-Jacquotte A; Wulff M; Johansson R; Schock H; Lenner P; Hallmans G; Wadell G; Toniolo P; Lundin E
Breast Cancer Res Treat; 2010 May; 121(1):169-75. PubMed ID: 19728079
[TBL] [Abstract][Full Text] [Related]
33. Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study.
Schock H; Zeleniuch-Jacquotte A; Lundin E; Grankvist K; Lakso HÅ; Idahl A; Lehtinen M; Surcel HM; Fortner RT
BMC Pregnancy Childbirth; 2016 Jul; 16(1):146. PubMed ID: 27377060
[TBL] [Abstract][Full Text] [Related]
34. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women.
Zeleniuch-Jacquotte A; Toniolo P; Levitz M; Shore RE; Koenig KL; Banerjee S; Strax P; Pasternack BS
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657
[TBL] [Abstract][Full Text] [Related]
35. Correlates of pregnancy oestrogen, progesterone and sex hormone-binding globulin in the USA and China.
Wuu J; Hellerstein S; Lipworth L; Wide L; Xu B; Yu GP; Kuper H; Lagiou P; Hankinson SE; Ekbom A; Carlström K; Trichopoulos D; Adami HO; Hsieh CC
Eur J Cancer Prev; 2002 Jun; 11(3):283-93. PubMed ID: 12131662
[TBL] [Abstract][Full Text] [Related]
36. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.
Nyante SJ; Gammon MD; Kaufman JS; Bensen JT; Lin DY; Barnholtz-Sloan JS; Hu Y; He Q; Luo J; Millikan RC
Cancer Causes Control; 2015 Jan; 26(1):121-31. PubMed ID: 25421376
[TBL] [Abstract][Full Text] [Related]
37. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
Schairer C; Hill D; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Sherman ME
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1660-5. PubMed ID: 16030098
[TBL] [Abstract][Full Text] [Related]
38. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
[TBL] [Abstract][Full Text] [Related]
39. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
Key TJ; Appleby PN; Reeves GK; Roddam A; Dorgan JF; Longcope C; Stanczyk FZ; Stephenson HE; Falk RT; Miller R; Schatzkin A; Allen DS; Fentiman IS; Key TJ; Wang DY; Dowsett M; Thomas HV; Hankinson SE; Toniolo P; Akhmedkhanov A; Koenig K; Shore RE; Zeleniuch-Jacquotte A; Berrino F; Muti P; Micheli A; Krogh V; Sieri S; Pala V; Venturelli E; Secreto G; Barrett-Connor E; Laughlin GA; Kabuto M; Akiba S; Stevens RG; Neriishi K; Land CE; Cauley JA; Kuller LH; Cummings SR; Helzlsouer KJ; Alberg AJ; Bush TL; Comstock GW; Gordon GB; Miller SR; Longcope C;
J Natl Cancer Inst; 2003 Aug; 95(16):1218-26. PubMed ID: 12928347
[TBL] [Abstract][Full Text] [Related]
40. Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer.
Toniolo P; Grankvist K; Wulff M; Chen T; Johansson R; Schock H; Lenner P; Hallmans G; Lehtinen M; Kaaks R; Wadell G; Zeleniuch-Jacquotte A; Lundin E; Lukanova A
Cancer Res; 2010 Sep; 70(17):6779-86. PubMed ID: 20713523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
